Accepted for/Published in: JMIR Medical Education
Date Submitted: Jan 22, 2025
Date Accepted: Dec 3, 2025
Date Submitted to PubMed: Dec 4, 2025
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Enhancing Medical Education: Implementing a Cancer Immunotherapy Elective for Medical Students
ABSTRACT
The rapid advancements in cancer immunotherapy have revolutionized the landscape of oncology, offering new hope and treatment paradigms for patients with various cancers. Cancer immunotherapy is a complex and evolving field with transformative potential, necessitating its inclusion in undergraduate medical education. We describe the design and implementation of a novel, online elective in cancer immunotherapy for fourth-year medical students. The elective was well received by the students and enhanced their understanding and interest in the field. The implementation of a cancer immunotherapy elective is a vital step towards enhancing medical education. A blueprint for the design and implementation of the elective is provided with the aim to bridge the gap between cutting-edge research, basic science and its clinical applications, and prepare the next generation of physicians to meet the challenges of modern oncology.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.